ストックスクリーナーアプリを入手
1.36
8.80%
0.11
アフターアワーズ：
1.35
-0.01
-0.74%
前日終値:
$1.25
開ける：
$1.22
24時間の取引高:
1.19M
Relative Volume:
2.02
時価総額：
$111.06M
収益：
-
当期純損益:
$-166.14M
株価収益率:
-0.7047
EPS:
-1.93
ネットキャッシュフロー:
$-139.92M
1週間 パフォーマンス:
+11.48%
1か月 パフォーマンス:
+97.10%
6か月 パフォーマンス:
+17.24%
1年 パフォーマンス:
-39.56%
1日の値動き範囲:
$1.22
$1.40
1週間の範囲:
$1.19
$1.408
52週間の値動き範囲:
$0.535
$3.405
Allakos Inc Stock (ALLK) Company Profile
Allakos Inc Stock (ALLK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-01-17 | ダウングレード | Jefferies | Buy → Hold |
| 2024-01-16 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-18 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-12-08 | 再開されました | Jefferies | Buy |
| 2023-09-27 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-05-12 | アップグレード | Jefferies | Hold → Buy |
| 2023-03-07 | 開始されました | Piper Sandler | Overweight |
| 2022-09-12 | ダウングレード | SMBC Nikko | Neutral → Underperform |
| 2021-12-22 | ダウングレード | BofA Securities | Buy → Underperform |
| 2021-12-22 | ダウングレード | Cowen | Outperform → Market Perform |
| 2021-12-22 | ダウングレード | Jefferies | Buy → Hold |
| 2021-12-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-12-22 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-08-26 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-07-15 | 開始されました | Cowen | Outperform |
| 2021-05-18 | 開始されました | H.C. Wainwright | Buy |
| 2021-02-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-01-15 | 開始されました | BofA Securities | Buy |
| 2020-12-21 | 開始されました | SVB Leerink | Outperform |
| 2020-02-27 | 開始されました | Barclays | Underweight |
| 2020-02-04 | 再開されました | Goldman | Neutral |
| 2018-08-13 | 開始されました | Goldman | Neutral |
| 2018-08-13 | 開始されました | Jefferies | Buy |
| 2018-08-13 | 開始されました | William Blair | Outperform |
すべてを表示
Allakos Inc (ALLK) 最新ニュース
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Allakos Inc. (NASDAQ:ALLK) Short Interest Down 17.1% in October - MarketBeat
3 US Penny Stocks With Market Caps Larger Than $50M - Simply Wall St
Allakos Insiders Miss 24% Gain After Offloading Stock - Simply Wall St
Vernal Keratoconjunctivitis Market Growth to Accelerate - openPR
The Manufacturers Life Insurance Company Sells 2,148 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Short Interest in Custom Truck One Source, Inc. (NYSE:CTOS) Decreases By 5.5% - Defense World
Nasal Polyposis Market Size is Set for Rapid Growth as Innovative - openPR
Chronic Spontaneous Urticaria Market Forecasted to Surge - openPR
Jefferies downgrades Allakos Inc (ALLK) stock to a Hold - Knox Daily
Allakos Inc (ALLK)’s stock price range in the last year - US Post News
Investor’s Delight: Allakos Inc (ALLK) Closes Weak at 0.65, Down -1.14 - The Dwinnex
Allakos shares hold rating after trial update By Investing.com - Investing.com Australia
Piper Sandler maintains Overweight rating on Allakos shares By Investing.com - Investing.com Australia
TD Cowen Reiterates Hold Rating on Allakos Inc. (ALLK) - StreetInsider.com
Piper Sandler maintains Overweight rating on Allakos shares - Investing.com India
Allakos shares hold rating after trial update - Investing.com
Allakos stock gains on trial data for lead drug (NASDAQ:ALLK) - Seeking Alpha
Piper Sandler Reiterates Overweight Rating on Allakos Inc. (ALLK) - StreetInsider.com
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - ForexTV.com
Allakos reports positive results from AK006 Phase 1 study - Investing.com India
Allakos Progress Update on AK006 and Future Milestones - TipRanks
Allakos reports positive results from AK006 Phase 1 study By Investing.com - Investing.com UK
Allakos (ALLK) Reports Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - StreetInsider.com
SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World
Vernal Keratoconjunctivitis Market to Show Remarkable Growth - openPR
Vernal Keratoconjunctivitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Santen SAS, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc - Barchart
Duff & Phelps Investment Management Co. Cuts Holdings in Enbridge Inc. (NYSE:ENB) - Defense World
Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions - MSN
Wall Street SWOT: Allakos stock faces pivotal year as AK006 data looms - Investing.com
Allakos (NASDAQ:ALLK) Receives Market Outperform Rating from JMP Securities - MarketBeat
Leerink Partners analysts initates a Market perform rating for Align Technology, Inc. (ALGN) - Knox Daily
Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's
French InsurTech Alan raises $193m to bolster tech and growth in Belgium - FinTech Global
Allied Properties Real Estate Investment Trust (TSE:AP.UN) Price Target Increased to C$18.50 by Analysts at Canaccord Genuity Group - MarketBeat
Aligos Therapeutics (NASDAQ:ALGS) Reaches New 52-Week Low at $8.28 - MarketBeat
Allogene Therapeutics Inc [ALLO] Stock bought by Insider Douglas Earl Martin for $78844.0 - Knox Daily
Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down to $11.43 - Defense World
Investing in Alta Equipment Group Inc (ALTG): What You Must Know - Knox Daily
Allegion Stock: Is ALLE Outperforming The Industrials Sector? - Barchart
Alumis Inc. [ALMS] Stock bought by Insider Foresite Labs, LLC for $40.0 million - Knox Daily
Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks
Views of Wall Street’s Leading Experts on Alta Equipment Group Inc - SETE News
Trading Day Triumph: Allogene Therapeutics Inc (ALLO) Ends at 2.80, a -3.78 Surge/Plunge - The Dwinnex
Ally Bridge Group NY LLC Reduces Holdings in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Alternus Clean Energy outlines plan to regain Nasdaq compliance - Proactive Investors Australia
Canada Pension Plan Investment Board Has $25.79 Million Position in Align Technology, Inc. (NASDAQ:ALGN) - Defense World
LKQ Co. (NASDAQ:LKQ) Shares Acquired by Lombard Odier Asset Management Europe Ltd - Defense World
Allakos Inc (ALLK)’s results reveal risk - US Post News
ALLO underperforms with a -3.78 decrease in share price - US Post News
An Analysis of Alkami Technology Inc (ALKT)’s Potential Price Growth - Knox Daily
Allakos Inc (ALLK) 財務データ
収益
当期純利益
現金流量
EPS
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):